Related Experiment Video
Updated: May 17, 2026
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Targeting the mycobacterial envelope for tuberculosis drug development
Lorenza Favrot1, Donald R Ronning
1Department of Chemistry, University of Toledo, Toledo, OH 43606, USA.
Expert Review of Anti-Infective Therapy
|October 31, 2012
Summary
Tuberculosis bacteria have a unique, tough outer membrane that protects them. New drug strategies aim to penetrate this barrier or weaken it to improve tuberculosis treatment.
Area of Science:
- Microbiology
- Drug Discovery
- Biochemistry
Background:
- Mycobacterium tuberculosis possesses a unique lipid-rich outer membrane, primarily composed of mycolic acids.
- This membrane acts as a permeability barrier, contributing to acid-fastness and survival in hostile environments.
- Effective antitubercular drugs must penetrate this formidable barrier to reach intracellular targets.
Purpose of the Study:
- To review current drug development efforts for tuberculosis.
- To identify novel enzyme targets and understand cell wall biosynthesis pathways.
- To explore strategies for weakening the mycobacterial outer membrane to reduce virulence and enhance drug efficacy.
Main Methods:
- Literature review of drug development pipelines.
- Analysis of research identifying new enzyme targets.
- Examination of studies on mycobacterial outer membrane and cell wall assembly.
- Review of discovery efforts targeting the permeability barrier.
Main Results:
- Highlighting progress in the tuberculosis drug pipeline.
- Identifying new enzymatic targets for drug development.
- Advancing understanding of essential biosynthetic pathways for the mycobacterial cell envelope.
- Exploring novel approaches to disrupt the permeability barrier.
Conclusions:
- Continued research is crucial for developing new tuberculosis drugs.
- Targeting the unique mycolic acid layer offers promising therapeutic avenues.
- Weakening the outer membrane could reduce bacterial virulence and improve existing treatments.
More Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...